Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Semaglutide-Induced Sarcopenia via GLP-1R-mTOR-Satellite Cells Axis and Muscle-Glucose Feedback Loop Potentially Leading to Refractory Hyperglycemia in Type 2 Diabetes: A Case-Driven Hypothesis
Problemy endokrinologii, 2026;72(3):60-65
[Safety Management of Incretin-Based Obesity Therapy: Expert Consensus on the Use of Semaglutide and Tirzepatide]
Problemy endokrinologii, 2026;72(3):36-43
Respiratory Adverse Events of Weight-Loss Drugs: A Systematic Review and Meta-Analysis
Annals of the American Thoracic Society, 2026
Oral Semaglutide and CV Benefits in the SOUL Trial: How Do Baseline or Changes in HbA1c or BMI Affect Clinical Outcomes?
The Journal of clinical endocrinology and metabolism, 2026
Safety Signals of GLP-1 Receptor Agonists: A Multi-Method Pharmacovigilance Analysis of FAERS (2018-2025) With Sensitivity-Stratified Prioritisation, Notoriety-Bias Assessment, and Cross-Database Validation
Diabetes, obesity & metabolism, 2026
Host-directed treatments for tuberculous meningitis utilizing a multi-platform approach across mouse and human models
Nature communications, 2026;17(1)
Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study
BMJ open, 2026;16(7):e109259
From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists
Translational research : the journal of laboratory and clinical medicine, 2026
GLP-1 Receptor Agonists as a Candidate Treatment for Opioid Use Disorder: From rats to humans
Biological psychiatry, 2026
Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to Human Reproduction
Biomedicines, 2026;14(7)
Signal thresholds and causal inference in pharmacovigilance studies of glucagon-like Peptide-1 receptor agonists
Clinical nutrition (Edinburgh, Scotland), 2026;64:106731
GLP-1 receptor agonists and psychiatric outcomes: a bibliometric analysis of research trends, thematic evolution, and collaboration networks
Frontiers in psychiatry, 2026;17:1857078
Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application
Journal of chromatography. A, 2026;1786:467288
Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations
Indian pediatrics, 2026
Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2026;:87551225261466571
Incretin-Based Therapies, Obesity-Associated Inflammation, and Atherosclerotic Cardiovascular Risk
Cells, 2026;15(14)
Linking pediatric obesity to youth-onset type 2 diabetes: integrated longitudinal and cross-sectional evidence from population-based studies worldwide
Clinical and experimental pediatrics, 2026
Letter to the Editor Regarding “Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists”
Spine, 2026
Severe Gastrointestinal Intolerance After Resuming Maintenance-Dose Semaglutide Following Ramadan-Related Treatment Interruption: A Case Report
Cureus, 2026;18(7):e113026
Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial
Diabetes, obesity & metabolism, 2026